-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTIMMUNE - PEMVIDUTIDE 2.4 MG ACHIEVES SIGNIFICANT REDUCTION IN HEAVY DRINKING DAYS IN PHASE 2 TRIAL

路透·07/28/2026 11:00:01

登录查看新闻详情